183 related articles for article (PubMed ID: 21938511)
1. Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease.
Yokoyama S; Takada K; Hirasawa M; Perera LP; Hiroi T
J Clin Immunol; 2011 Dec; 31(6):1038-44. PubMed ID: 21938511
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes.
Yokoyama S; Watanabe N; Sato N; Perera PY; Filkoski L; Tanaka T; Miyasaka M; Waldmann TA; Hiroi T; Perera LP
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15849-54. PubMed ID: 19805228
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease.
Yokoyama S; Perera PY; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2013 Apr; 33(3):586-94. PubMed ID: 23269601
[TBL] [Abstract][Full Text] [Related]
4. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
5. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.
Di Sabatino A; Ciccocioppo R; Cupelli F; Cinque B; Millimaggi D; Clarkson MM; Paulli M; Cifone MG; Corazza GR
Gut; 2006 Apr; 55(4):469-77. PubMed ID: 16105889
[TBL] [Abstract][Full Text] [Related]
6. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking.
Barone MV; Zanzi D; Maglio M; Nanayakkara M; Santagata S; Lania G; Miele E; Ribecco MT; Maurano F; Auricchio R; Gianfrani C; Ferrini S; Troncone R; Auricchio S
PLoS One; 2011 Feb; 6(2):e17039. PubMed ID: 21364874
[TBL] [Abstract][Full Text] [Related]
7. Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes.
Porpora M; Conte M; Lania G; Bellomo C; Rapacciuolo L; Chirdo FG; Auricchio R; Troncone R; Auricchio S; Barone MV; Nanayakkara M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216089
[TBL] [Abstract][Full Text] [Related]
8. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.
Malamut G; El Machhour R; Montcuquet N; Martin-Lannerée S; Dusanter-Fourt I; Verkarre V; Mention JJ; Rahmi G; Kiyono H; Butz EA; Brousse N; Cellier C; Cerf-Bensussan N; Meresse B
J Clin Invest; 2010 Jun; 120(6):2131-43. PubMed ID: 20440074
[TBL] [Abstract][Full Text] [Related]
9. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
10. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
Lindfors K; Kaukinen K; Mäki M
Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
12. IL-15: a central regulator of celiac disease immunopathology.
Abadie V; Jabri B
Immunol Rev; 2014 Jul; 260(1):221-34. PubMed ID: 24942692
[TBL] [Abstract][Full Text] [Related]
13. Evidence That Pathogenic Transglutaminase 2 in Celiac Disease Derives From Enterocytes.
Iversen R; Amundsen SF; Kleppa L; du Pré MF; Stamnaes J; Sollid LM
Gastroenterology; 2020 Aug; 159(2):788-790. PubMed ID: 32302613
[No Abstract] [Full Text] [Related]
14. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
[TBL] [Abstract][Full Text] [Related]
15. Intracellular Localization of Microbial Transglutaminase and Its Influence on the Transport of Gliadin in Enterocytes.
Stricker S; de Laffolie J; Rudloff S; Komorowski L; Zimmer KP
J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):e43-e50. PubMed ID: 30320664
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease: Autoimmunity in response to food antigen.
Stamnaes J; Sollid LM
Semin Immunol; 2015 Sep; 27(5):343-52. PubMed ID: 26603490
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-21 levels from celiac disease patients correlates with anti-tTG IgA autoantibodies and mucosal damage.
Iervasi E; Auricchio R; Strangio A; Greco L; Saverino D
Autoimmunity; 2020 Jun; 53(4):225-230. PubMed ID: 32157915
[No Abstract] [Full Text] [Related]
18. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease: an immunological jigsaw.
Meresse B; Malamut G; Cerf-Bensussan N
Immunity; 2012 Jun; 36(6):907-19. PubMed ID: 22749351
[TBL] [Abstract][Full Text] [Related]
20. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
